Literature DB >> 2340601

Biophysical inhibition of synthetic lung surfactants.

B A Holm1, A R Venkitaraman, G Enhorning, R H Notter.   

Abstract

The biophysical activity and inhibition of a series of synthetic surfactant mixtures was studied and correlated with physiological effectiveness in restoring pressure-volume (P-V) mechanics of excised lungs. Results showed that several simple mixtures of dipalmitoyl phosphatidylcholine (DPPC) with fatty acids or diacylglycerols could be formulated to give good adsorption facility and dynamic surface tension lowering to less than 1 mN/m in pulsating bubble measurements at 37 degrees C. However, although biophysical activity approached that of natural lung surfactant (LS) and a related surfactant extract (CLSE) under normal conditions, surface properties were sharply inhibited by relatively small amounts of the plasma protein albumin (2 mg/ml) with minimum surface tensions greater than 30 nM/m even at high surfactant concentrations (5-20 mg lipids/ml). This sensitivity to biophysical inhibition was markedly increased compared to LS and CLSE, and had direct consequences for physiological efficacy: in spite of initially high activity, synthetic surfactants did not exert beneficial effects on P-V mechanics when instilled into surfactant-deficient excised rat lungs. Endogenous protein material was shown to be present upon surfactant recovery by lavage, and bubble measurements confirmed surface activity well below pre-instillation levels. Moreover, full biophysical activity was restored when lavage fluid was extracted to separate the synthetic surfactants from endogenous inhibitors. These results show that it is important to define relative sensitivity to biophysical inhibition in the development of effective lung surfactant substitutes. In addition, the existence of inhibition effects can generate an apparent lack of correspondence between initial biophysical activity and ultimate physiological actions of exogenous surfactant mixtures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340601     DOI: 10.1016/0009-3084(90)90120-g

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  9 in total

1.  A concentration-dependent mechanism by which serum albumin inactivates replacement lung surfactants.

Authors:  H E Warriner; J Ding; A J Waring; J A Zasadzinski
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

2.  Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.

Authors:  H William Taeusch; Jorge Bernardino de la Serna; Jesus Perez-Gil; Coralie Alonso; Joseph A Zasadzinski
Journal:  Biophys J       Date:  2005-05-27       Impact factor: 4.033

3.  Inflammation product effects on dilatational mechanics can trigger the Laplace instability and acute respiratory distress syndrome.

Authors:  Sourav Barman; Michael L Davidson; Lynn M Walker; Shelly L Anna; Joseph A Zasadzinski
Journal:  Soft Matter       Date:  2020-07-29       Impact factor: 3.679

Review 4.  Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.

Authors:  Joseph A Zasadzinski; Patrick C Stenger; Ian Shieh; Prajna Dhar
Journal:  Biochim Biophys Acta       Date:  2009-12-22

5.  In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function.

Authors:  B Lachmann; E P Eijking; K L So; D Gommers
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

6.  Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro.

Authors:  Mandeep Singh Bakshi; Lin Zhao; Ronald Smith; Fred Possmayer; Nils O Petersen
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

7.  Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.

Authors:  Zhengdong Wang; Yusuo Chang; Adrian L Schwan; Robert H Notter
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-07       Impact factor: 6.914

Review 8.  The Efficacy of Surfactant Replacement Therapy in the Growth-Restricted Preterm Infant: What is the Evidence?

Authors:  Atul Malhotra; Arun Sasi; Suzanne L Miller; Graham Jenkin; Graeme R Polglase
Journal:  Front Pediatr       Date:  2014-10-29       Impact factor: 3.418

Review 9.  Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.

Authors:  W Seeger; A Günther; H D Walmrath; F Grimminger; H G Lasch
Journal:  Clin Investig       Date:  1993-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.